Atara Biotherapeutics, Inc.

ATRANasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$120.8M

▼ 6.3% YoY

Net Income

$32.7M

▲ 138.3% YoY

EPS

$2.57

▲ 122.5% YoY

Cash

$8.5M

▼ 66.1% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.